Skip to main content
# العنوان المشارك في البحث سنة البحث
81 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom د. أميرة محمود محمد عثمان 2018
82 Acute Complications After High-Dose Chemotherapy and Stem-Cell Rescue in Pediatric Patients With High-Risk Neuroblastoma Treated in Countries With Different Resources د. خالد فتحى رياض عثمان 2018
83 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom أ.د.أمانى محمد على أحمد 2018
84 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom
أ.د.أمانى محمد على أحمد 2018
85 HCMV Among Pediatrics Acute Lymphoblastic Leukemia Patients in South Egypt Cancer Institute د. خالد فتحى رياض عثمان 2018
86 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom د. طارق محمد عبدالمنعم محمد السبع أحمد 2018
87 Flowcytometric CD135 Expression
and its Impact on Pediatric Acute
Lymphoblastic Leukemia at South Egypt
Cancer Institute
أ.د.هبة عبدالرازق سيد حسين 2018
88 Flowcytometric CD135 Expression
and its Impact on Pediatric Acute
Lymphoblastic Leukemia at South Egypt
Cancer Institute
د. عزه شبل سيد محمود 2018
89 Evaluation of Surgical Methods for Treatment of Cubital Tunnel Syndrome – Statistical Perspectives د. أحمد محمد مرسي حسن 2017
90 Can Pediatric Risk of Mortality Score (PRISM III) Be Used Effectively in Initial Evaluation and Follow-up of Critically Ill Cancer Patients Admitted to Pediatric Oncology Intensive Care Unit (POICU)? A Prospective Study, in a Tertiary Cancer Center in Egy محمود معتز الزمبيلي 2017